Professional paper
Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine
Zlatko Balog
Tanja Jukić-Lešina
Full text: croatian pdf 1.685 Kb
page 199-202
downloads: 181
cite
APA 6th Edition
Balog, Z. & Jukić-Lešina, T. (1999). Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik, 31 ((1-4)), 199-202. Retrieved from https://hrcak.srce.hr/index.php/191994
MLA 8th Edition
Balog, Zlatko and Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik, vol. 31, no. (1-4), 1999, pp. 199-202. https://hrcak.srce.hr/index.php/191994. Accessed 27 Sep. 2024.
Chicago 17th Edition
Balog, Zlatko and Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik 31, no. (1-4) (1999): 199-202. https://hrcak.srce.hr/index.php/191994
Harvard
Balog, Z., and Jukić-Lešina, T. (1999). 'Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine', Medicinski vjesnik, 31((1-4)), pp. 199-202. Available at: https://hrcak.srce.hr/index.php/191994 (Accessed 27 September 2024)
Vancouver
Balog Z, Jukić-Lešina T. Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik [Internet]. 1999 [cited 2024 September 27];31((1-4)):199-202. Available from: https://hrcak.srce.hr/index.php/191994
IEEE
Z. Balog and T. Jukić-Lešina, "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine", Medicinski vjesnik, vol.31, no. (1-4), pp. 199-202, 1999. [Online]. Available: https://hrcak.srce.hr/index.php/191994. [Accessed: 27 September 2024]
Full text: english pdf 1.685 Kb
page 199-202
downloads: 1.339
cite
APA 6th Edition
Balog, Z. & Jukić-Lešina, T. (1999). Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik, 31 ((1-4)), 199-202. Retrieved from https://hrcak.srce.hr/index.php/191994
MLA 8th Edition
Balog, Zlatko and Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik, vol. 31, no. (1-4), 1999, pp. 199-202. https://hrcak.srce.hr/index.php/191994. Accessed 27 Sep. 2024.
Chicago 17th Edition
Balog, Zlatko and Tanja Jukić-Lešina. "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine." Medicinski vjesnik 31, no. (1-4) (1999): 199-202. https://hrcak.srce.hr/index.php/191994
Harvard
Balog, Z., and Jukić-Lešina, T. (1999). 'Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine', Medicinski vjesnik, 31((1-4)), pp. 199-202. Available at: https://hrcak.srce.hr/index.php/191994 (Accessed 27 September 2024)
Vancouver
Balog Z, Jukić-Lešina T. Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine. Medicinski vjesnik [Internet]. 1999 [cited 2024 September 27];31((1-4)):199-202. Available from: https://hrcak.srce.hr/index.php/191994
IEEE
Z. Balog and T. Jukić-Lešina, "Frequency of retinopathy in patients with rheumatoid arthritis treated by chlorochine", Medicinski vjesnik, vol.31, no. (1-4), pp. 199-202, 1999. [Online]. Available: https://hrcak.srce.hr/index.php/191994. [Accessed: 27 September 2024]
Abstract
Chloroquine phosphate is a 4-aminoquinoline compound widely accepted as the "second line antirheumatic drug" ("disease modifying drug", "basic drug") in the treatment of patients with rheumatoid arthritis. The original enthusiasm for this compound diminished after the recognition of serious retinal damage. We treated 24 patients during 8 (1) to 96 months (total: 643 months or in average 26,79 months) with Chlorochine in 250 mg daily doses. The ophthalmological examinations were repeatedly done every 4.5 to 5.5 months. One female patient showed transient of the first isoptere after 26 months of treatment and 1 female patient after 2 and half years of treatment was found as having perimacular bilateral pigment disgrupations. Our experience is that ocular toxicity is infrequent and can be minimized by careful and permanent ophthalmological control.
Keywords
Chlorochine; Retinopathy; Rheumatoid arthritis
Hrčak ID:
191994
URI
https://hrcak.srce.hr/191994
Publication date:
1.12.1999.
Article data in other languages:
croatian
Visits: 2.177
*